Spyre Therapeutics, Inc. (SYRE)
Spyre Therapeutics, Inc. (SYRE) has a 42-report earnings history dating back to May 19, 2016. Its average absolute post-earnings move is ±3.79%, and 54.8% of those reactions were positive. Its largest post-earnings gain was +14.28% (Feb 19, 2026) and its largest decline was -6.56% (Nov 03, 2022). The next earnings report is predicted for 2026-08-11 (approximate).
Earnings reactions
How SYRE moved on each past earnings report.
Earnings Impact
Total Earnings
42
Avg Abs. Movement
±3.79%
Positive %
54.8%
Negative %
45.2%
Historical Earnings Statistics
| Date | Timing | Earnings move | SEC Filing |
|---|---|---|---|
| May 05, 2026 | ☀ PRE | +2.73% | open_in_new |
| Apr 13, 2026 | ☽ POST | +1.17% | open_in_new |
| Feb 19, 2026 | ☽ POST | +14.28% | open_in_new |
| Nov 04, 2025 | ☽ POST | -0.57% | open_in_new |
Earnings Count
42
Total earnings in dataset
Avg Abs. Movement
±3.79%
Avg % price change on earnings
Institutional ownership
Holdings as of Mar 31, 2026 · SEC 13-F
SEC Filing Types
Recent SEC Filings
10 most recent| Form | Date Filed | View on EDGAR |
|---|---|---|
| 4 | 20260702 | open_in_new SEC.gov |
| 4 | 20260702 | open_in_new SEC.gov |
| 4 | 20260702 | open_in_new SEC.gov |
| 144 | 20260701 | open_in_new SEC.gov |
| 4 | 20260626 | open_in_new SEC.gov |
| S-3ASR | 20260626 | open_in_new SEC.gov |
| 144 | 20260625 | open_in_new SEC.gov |
| 144 | 20260623 | open_in_new SEC.gov |
| 4 | 20260623 | open_in_new SEC.gov |
| 4 | 20260623 | open_in_new SEC.gov |
Frequently asked about SYRE earnings
When does Spyre Therapeutics, Inc. report earnings next? expand_more
Spyre Therapeutics, Inc. (SYRE)'s next earnings date is approximate for 2026-08-11. This is a prediction based on its historical quarterly reporting pattern, not a company-confirmed date.
How much does SYRE stock move after earnings? expand_more
Over 42 reports, SYRE has moved an average of ±3.79% the session after earnings, closing higher 54.8% of the time.
What was SYRE's biggest post-earnings move? expand_more
SYRE's largest post-earnings gain on record was +14.28% on Feb 19, 2026, and its largest decline was -6.56% on Nov 03, 2022.
Where can I find Spyre Therapeutics, Inc.'s SEC filings? expand_more
All of Spyre Therapeutics, Inc.'s SEC filings — 10-K, 10-Q, 8-K and more — are listed in the SEC filings section on this page, each linking to the original document on SEC.gov.
Sector peers
- Aardvark Therapeutics, Inc. (AARD) earnings history chevron_right
- AbCellera Biologics Inc. Common Shares (ABCL) earnings history chevron_right
- ABEONA THERAPEUTICS INC. (ABEO) earnings history chevron_right
- Acumen Pharmaceuticals, Inc. Common Stock (ABOS) earnings history chevron_right
- Arbutus Biopharma Corp (ABUS) earnings history chevron_right
- ABVC BioPharma, Inc. Common Stock (ABVC) earnings history chevron_right
- ACADIA PHARMACEUTICALS INC (ACAD) earnings history chevron_right
- Adicet Bio, Inc. Common Stock (ACET) earnings history chevron_right
- Acadia Healthcare Company, Inc. Common Stock (ACHC) earnings history chevron_right
- Achieve Life Sciences, Inc. Common Shares (ACHV) earnings history chevron_right